Delta-9-tetrahydrocannabinol (D 9 -THC) has profound effects on higher cognitive functions, and exposure to D 9 -THC has been associated with the appearance or exacerbation of the clinical features of schizophrenia. These actions appear to be mediated via the CB 1 receptor, the principal cannabinoid receptor expressed in the brain. However, the distribution of the CB 1 receptor in neocortical regions of the primate brain that mediate cognitive functions is not known. We therefore investigated the immunocytochemical localization of the CB 1 receptor in the brains of macaque monkeys and humans using antibodies that specifically recognize the N-or C-terminus of the CB 1 receptor. In monkeys, intense CB 1 immunoreactivity was observed primarily in axons and boutons. Across neocortical regions of the monkey brain, CB 1 -immunoreactive (IR) axons exhibited considerable heterogeneity in density and laminar distribution. Neocortical association regions, such as the prefrontal and cingulate cortices, demonstrated a higher density, and exhibited a unique laminar pattern of CB 1 -IR axons, compared with primary sensory and motor cortices. Similar regional and laminar distributions of CB 1 -IR axons were also present in the human neocortex. CB 1 -IR axons had more prominent varicosities in human tissue, but this difference appeared to represent a postmortem effect as similar morphological features increased in unperfused monkey tissue as a function of postmortem interval. In electron microscopy studies of perfused monkey prefrontal cortex, CB 1 immunoreactivity was predominantly found in axon terminals that exclusively formed symmetric synapses. The high density, distinctive laminar distribution, and localization to inhibitory terminals of CB 1 receptors in primate higher-order association regions suggests that the CB 1 receptor may play a critical role in the circuitry that subserves cognitive functions such as those that are disturbed in schizophrenia.
Introduction
Marijuana, a preparation of the hemp plant Cannabis sativa, is one of the oldest known recreational drugs, and today it is one of the most widely abused illicit drugs (Watson and others 2000) . Delta-9-tetrahydrocannabinol (D 9 -THC), the chief psychoactive cannabinoid in cannabis, has profound effects on mood and a number of cognitive functions (reviewed in Childers and Breivogel 1998; Ameri 1999) . In addition, cannabis use has been associated with both an increased risk of, and greater symptom severity in, psychiatric disorders such as schizophrenia (reviewed in Smit and others 2004) . Thus, understanding the molecular mechanisms by which cannabinoids elicit their effects is of substantial interest and clinical importance.
The demonstration of selective and specific binding of a radiolabeled synthetic derivative of D 9 -THC to brain tissue revealed the presence of a central brain cannabinoid receptor (designated CB 1 ) (Devane and others 1988) . This finding led to the cloning of the brain CB 1 receptor (Matsuda and others 1990) and the identification of a peripheral CB 2 receptor (Munro and others 1993) , both of which are G protein--coupled receptors. The discovery of the endogenous cannabinoids anandamide (Devane and others 1992) and 2-arachidonoylglycerol (Mechoulam and others 1995) and the development of selective synthetic ligands that bind to the 2 receptor types others 1994, 1998) soon followed.
Most of the physiological and behavioral effects of cannabinoids appear to be mediated by the CB 1 receptor (Zimmer and others 1999) , which is highly expressed and widely distributed in the brain (Herkenham and others 1991; Matsuda and others 1993; Glass and others 1997) . In particular, high levels of the CB 1 receptor are expressed in neocortical association areas such as the prefrontal cortex and the cingulate cortex (Herkenham and others 1991; Matsuda and others 1993; Glass and others 1997) , which are known to mediate executive functions. Other regions involved in cognitive functioning, such as the hippocampus, basal ganglia, and cerebellum, also express high levels of the CB 1 receptor (Herkenham and others 1991; Matsuda and others 1993; Glass and others 1997; Biegon and Kerman 2001) . Therefore, CB 1 receptors in these regions may mediate certain deficits in cognitive functions observed following cannabinoid administration in humans and animals (Winsauer and others 1999; Schneider and Koch 2003; D'Souza and others 2004) .
In rodents, the CB 1 receptor is almost exclusively expressed by gamma-aminobutyric acid (GABA) interneurons in the neocortex, hippocampus, and basal nuclei of the amygdala. Indeed, in situ hybridization experiments in the mouse neocortex and hippocampus have demonstrated that 100% of neurons that express high levels of CB 1 mRNA also express mRNA for the 65-kDa isoform of glutamic acid decarboxylase 65, a synthesizing enzyme of GABA (Marsicano and Lutz 1999) . Furthermore, duallabel in situ hybridization and dual-label electron microscopy experiments in the rodent neocortex, hippocampus, and amygdala revealed that the CB 1 receptor is preferentially expressed by, and predominantly localized in, the terminals of the subtype of GABA basket interneurons that contain the neuropeptide cholecystokinin (CCK). In contrast, CB 1 is not found in GABA neurons containing the calcium-binding protein parvalbumin (PV) others 1999, 2001; Marsicano and Lutz 1999; Hajos and others 2000; Bodor and others 2005) . Consistent with this anatomical localization of the CB 1 receptor, electrophysiological studies have demonstrated that CB 1 agonists affect GABA neurotransmission. For instance, in in vitro slices of rodent neocortex, hippocampus, and amygdala, CB 1 agonists inhibit the release of GABA from neurons and reduce the amplitude of inhibitory postsynaptic currents others 1999, 2001; Hajos and others 2000; Trettel and others 2004; Bodor and others 2005) . Furthermore, systemic administration of CB 1 agonists decreases GABA levels in the rat neocortex in vivo as measured by microdialysis (Pistis and others 2002) .
Together, these observations suggest that the endogenous cannabinoid system plays an integral role in modulating GABA synaptic neurotransmission. However, understanding the involvement of CB 1 receptor--mediated signaling in cognitive functions and in the impairment of these abilities in schizophrenia requires knowledge of the anatomical localization of this receptor in the primate neocortex, especially in areas such as the prefrontal cortex where GABA neurotransmission is critical for cognitive functions (Sawaguchi and others 1988; Rao and others 2000) . However, in the 2 studies that previously investigated the immunocytochemical distribution of the CB 1 receptor in the monkey neocortex, the antibody that was used produced a pattern of labeling not entirely consistent with electrophysiological and pharmacological affects of CB 1 agonists or the anatomical localization of the CB 1 receptor in rodents (Lu and others 1999; Ong and Mackie 1999) . Furthermore, although the immunocytochemical localization of CB 1 in CCK interneurons in the human hippocampus (Katona and others 2000) and the autoradiographic distribution of CB 1 receptor--binding sites across certain human neocortical regions (Glass and others 1997; Biegon and Kerman 2001) appear to be conserved from the rodent (Herkenham and others 1991; Katona and others 1999) , the immunocytochemical distribution of the CB 1 receptor in the human brain has not been examined outside of the hippocampus. Consequently, we used immunocytochemical techniques and antibodies that specifically recognize the N-or C-terminus of the CB 1 receptor to examine the regional and laminar distribution of the CB 1 receptor in the neocortex of macaque monkeys and humans. In addition, we used immunoelectron microscopy in order to determine the cellular localization and cell types that express the CB 1 receptor in the monkey dorsolateral prefrontal cortex.
Materials and Methods

Light Microscopy
Perfused Monkey Specimens Eight adult male long-tailed macaque monkeys (Macaca fascicularis) were utilized for light microscopy. Housing and experimental procedures were conducted in accordance with United States Department of Agriculture and National Institutes of Health guidelines and with approval of the University of Pittsburgh's Institutional Animal Care and Use Committee. Monkeys were deeply anesthetized with ketamine hydrochloride (25 mg/kg) and sodium pentobarbital (30 mg/kg), intubated, mechanically ventilated with 28% O 2 /air, and perfused transcardially with ice-cold 1% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) followed by 4% paraformaldehyde in phosphate buffer, as previously described (Oeth and Lewis 1993) . Brains were immediately removed, blocked into 5-to 6-mm-thick coronal or sagittal blocks, and postfixed for 6 h in phosphate-buffered 4% paraformaldehyde at 4°C. Tissue blocks were subsequently immersed in cold sucrose solutions of increasing concentrations (12%, 16%, and 18%) and then stored at -30°C in a cryoprotectant solution containing glycerine and ethylene glycol in dilute phosphate buffer. We have previously shown that this storage procedure does not affect immunoreactivity for a number of antigens (see Cruz and others 2003) . Tissue blocks from either the left or the right hemisphere were sectioned coronally or sagittally at 40 lm on a cryostat, and every 10th section was stained for Nissl substance with thionin.
Human Autopsy Subjects
Brain specimens from 6 (4 male and 2 female) human subjects (20--38 years of age; postmortem interval [PMI] 4.5--8.5 h) were obtained from autopsies conducted at the Allegheny County Coroner's Office, Pittsburgh, PA, following informed consent for brain donation from the next of kin. None of the subjects had a history of psychiatric or neurologic disorders as determined by information obtained from clinical records and a structured interview conducted with a surviving relative. Neuropathological examinations revealed no abnormalities in any subject. All procedures were performed with the approval of the University of Pittsburgh's Institutional Review Board for Biomedical Research.
Following retrieval of brain specimens, the left hemisphere was cut into 1.0-cm coronal blocks and immersed in phosphate-buffered 4% paraformaldehyde for 48 h at 4°C. Tissue blocks were subsequently immersed in graded sucrose solutions and stored as described earlier. Tissue blocks containing the superior frontal gyrus (dorsolateral prefrontal cortex) or the calcarine sulcus (primary visual cortex) were sectioned coronally as described earlier.
Unperfused Monkey Specimens
One adult male long-tailed macaque monkey (M. fascicularis) was used to investigate the effect of PMI on CB 1 immunoreactivity. The monkey was deeply anesthetized as described earlier and the brain was immediately removed, cut into 3-to 5-mm-blocks, and immersed in ice-cold 0.01 M phosphate-buffered saline (PBS; pH 7.4). Following PMIs of 2, 12, 24, or 48 h, adjacent tissue blocks were transferred to cold phosphate-buffered 4% paraformaldehyde for 48 h. Tissue blocks were then immersed in sucrose solutions and stored as described earlier. Blocks containing the dorsolateral prefrontal cortex for each PMI were sectioned on a cryostat as described earlier.
Immunocytochemistry
For perfused monkeys, free-floating tissue sections were thoroughly washed in 0.01 M PBS and then treated for 30 min with a blocking solution containing 0.3% Triton X-100 and 4.5% normal donkey sera (NDS) and normal human sera (NHuS) at room temperature in PBS. Tissue sections were subsequently incubated for 48 h at 4°C in PBS containing 0.3% Triton X-100, 3% NDS and NHuS, 0.05% bovine serum albumin (BSA), and an affinity-purified polyclonal rabbit anti-CB 1 antibody raised against either the N-terminus of the human CB 1 receptor (residues 1--99; Sigma, St. Louis, MO; diluted 1:1000), the entire C-terminus of the rat CB 1 receptor (anti-CB 1 --CT) (residues 401--473; diluted 1:5000), or the last 15 amino acid residues of the rat CB 1 receptor (anti-CB 1 --L15) (diluted 1:5000). Both the C-terminus antibodies were kindly provided by Dr Ken Mackie (University of Washington, Seattle, WA). Sections were then incubated for 1 h in a biotinylated anti-rabbit IgG secondary antibody made in donkey (diluted 1:200; Jackson ImmunoResearch, West Grove, PA) followed by processing with the avidin--biotin--peroxidase method (Hsu and others 1981) using the Vectastain Avidin-Biotin Elite Kit (Vector Laboratories, Burlingame, CA). The immunoperoxidase reaction was visualized using 3,39-diaminobenzidine (DAB; Sigma), mounted on gelcoated slides, and air-dried. The DAB reaction product was stabilized by serial immersions in osmium tetroxide (0.005%) and thiocarbohydrazide (0.5%) as previously described (Lewis and others 1986) .
Human and unperfused monkey tissue sections were processed with the anti-CB 1 --L15 in the same manner except that they were initially pretreated with 1% hydrogen peroxide for 15 min to remove endogenous peroxidase activity.
Analysis of Neocortical Laminar Patterns
The laminar patterns of CB 1 immunoreactivity observed across different neocortical regions were assessed using a Microcomputer Imaging Device (MCID) system (Imaging Research Inc, London, ON, Canada). Slide-mounted sections containing selected neocortical regions were transilluminated on a light box, and images were captured by a video camera under precisely controlled conditions and digitized. Within each cytoarchitectonic region, a rectangle~1-mm wide extending from the pial surface to white matter was drawn and the optical density within each rectangle was measured. Optical density values were divided into 100 bins using Matlab software (The MathWorks, Natick, MA) and normalized within each cytoarchitectonic region by dividing the value of each bin by the value of the maximum bin. Laminar boundaries were determined by calculating the percent depth of each layer in adjacent Nissl-stained sections using the Neurolucida program (MicroBrightfield, Inc., Colchester, VT). Values from layer 1 were not reported due to edge effects that produced high optical density values even though layer 1 did not contain CB 1 -immunoreactive (IR) axons in most regions. Optical density values for each selected region were obtained from a single traverse from one animal each. A systematic analysis across multiple animals was not performed due to a lack of available tissue containing each region studied from every animal. However, the overall density and laminar patterns were confirmed in at least 2 animals for each region qualitatively.
Electron Microscopy
Animals and Tissue Preparation
For electron microscopy studies, 2 additional adult male long-tailed macaque monkeys (M. fascicularis) were deeply anesthetized as described earlier and transcardially perfused with room temperature 1% paraformaldehyde and 0.05% glutaraldehyde in 0.1 M phosphate buffer followed by 4% paraformaldehyde and 0.2% glutaraldehyde in the same buffer as previously reported (Melchitzky and others 2005) . Brains were immediately removed, blocked coronally into 5-mm-thick blocks, and postfixed for 2 h in phosphate-buffered 4% paraformaldehyde at 4°C. Tissue blocks were subsequently washed in 0.1 M phosphate buffer, and blocks containing prefrontal cortex area 46 were sectioned coronally at 50 lm on a vibrating microtome.
Immunocytochemistry
Free-floating tissue sections were initially treated with 1% sodium borohydride in 0.1 M phosphate buffer for 30 min followed by several washes in 0.1 M phosphate buffer to improve antigenicity and reduce nonspecific immunoreactivity (Sesack and others 1998) . Sections were incubated for 30 min in a blocking solution containing 0.2% BSA, 0.04% Triton X-100, 3% NDS, and 3% NHuS in 0.01 M PBS (pH 7.4) to further reduce nonspecific labeling. Sections were subsequently incubated overnight in blocking solution containing the anti-CB 1 --CT primary antibody (diluted 1:5000). On the following day, sections were rinsed in PBS and incubated for 1 h in blocking solution containing a biotinylated anti-rabbit IgG secondary antibody made in donkey (diluted 1:200; Jackson ImmunoResearch). Following rinses in PBS, sections were processed with the avidin--biotin--peroxidase method and visualized with DAB as described earlier. Tissue sections were then postfixed in 2% osmium tetroxide for 1 h in phosphate buffer, dehydrated in ascending alcohol solutions, and embedded in Epon 812 (EM bed 812; Electron Microscopy Sciences, Fort Washington, PA) as previously described (Sesack and others 1995) .
Sampling Regions and Procedures
For each animal, trapezoid blocks were cut from layer 4 of area 46 ( Fig. 1A ) and sectioned on a Reichert ultramicrotome (Nussloch, Figure 1 . Brightfield photomicrographs of CB 1 immunoreactivity in area 46 of the monkey prefrontal cortex produced by the anti-CB 1 --CT (A, D), anti-CB 1 --L15 (B, E), and the Nterminus antibodies (C, F). All 3 antibodies labeled numerous fibers that were thin and rich in varicosities and produced similar laminar patterns of immunoreactivity. Some labeled axons formed dense ''baskets'' surrounding unlabeled cell bodies (D--F). In addition, intensely labeled CB 1 -IR neurons were present in layers 2 and superficial 3 (arrows). In panels A--C numbers and hash marks to the left indicate the relative positions of the cortical layers, and the dashed lines denote the layer 6-white matter (WM) border. The trapezoid in panel A shows the approximate laminar location of blocks examined for electron microscopy. Scale bars = 300 lm in C (applies to A, B, C) and 10 lm in F (applies to D, E, F). Germany) at 80 nm. Two to four ultrathin sections were serially collected on 200-mesh copper grids and counterstained with uranyl acetate and lead citrate. For each trapezoid block 2--3 grids, separated by at least 10 grids, were examined. Grids were examined on an FEI Morgagni transmission microscope (Hillsboro, OR) and micrographs containing CB 1 -labeled structures were captured as digital images using an AMT XP-60 digital camera (Danvers, MA) and stored for later analysis.
Identification of Neuronal and Synaptic Elements
Neuronal elements encountered in electron micrographs were identified according to previous descriptions (Peters and others 1991) . Briefly, perikarya were identified by the presence of a nucleus. Dendritic shafts were identified by the presence of synaptic inputs, mitochondria, microtubules, and neurofilaments, whereas dendritic spines were characterized by the absence of both organelles and microtubules. Asymmetric synapses (Gray's type I) were identified by the widening and parallel spacing of apposed plasmalemmal surfaces, the presence of a prominent postsynaptic density, and round small synaptic vesicles. Symmetric synapses (Gray's type II) were identified by the presence of intercleft filaments, a thin postsynaptic density, and pleomorphic small synaptic vesicles.
Antibody Specificity
The specificity of the antibodies raised against the entire C-terminus of the rat CB 1 receptor has been verified by several lines of evidence. First, when tested in tissue from CB 1 knockout mice, no immunolabeling was observed (Hajos and others 2000; Katona and others 2001) . Second, western blotting of rat brain homogenates produced bands at the predicted molecular weights based on the amino acid sequence of the CB 1 receptor. Third, the CB 1 antibody labeled ATt20 cells transfected with the CB1 receptor but did not label untransfected cells (Hajos and others 2000; Katona and others 2001) . In addition, we preadsorbed the anti-CB 1 --CT and anti-CB 1 --L15 antibodies with 1 lg/mL of their respective cognate peptides. We also preadsorbed the anti-CB1--L15 antibody with the anti-CB1--CT fusion peptide and vice versa (see Results).
Nomenclature
Neocortical regions were identified on adjacent Nissl-stained sections based on previously published cytoarchitectonic and connectional analyses in the macaque monkey and the atlas of Paxinos and others (2000) (for regional abbreviations see Table 1 ). Frontal lobe cytoarchitectonic delineations used the criteria and terminology of Barbas and Pandya (1989) and Carmichael and Price (1994) . Regions of the cingulate cortex were identified following the divisions of Vogt and others (1987) and Morecraft and others (2004) . In the temporal lobe, the terminology of Amaral and others (1987) was used for the subregions of the entorhinal cortex, and regions of the superior temporal sulcus (TE and TEO) were defined according to Seltzer and Pandya (1989) . The auditory regions in the superior temporal gyrus were identified according to the cytoarchitectonic criteria of Galaburda and Pandya (1983) , using the updated parcellation and nomenclature of Hackett and others (1998) . In this nomenclature, AI and R compose the core auditory cortex; association belt regions are designated RM, AL, and ML; and parabelt regions are designated RP and CP. Divisions of the insular cortex were classified according to Mesulam and Mufson (1982) . In the parietal postcentral gyrus, primary somatosensory areas 3, 1, and 2 were identified based on the studies of Burton and others (1995) and Cipolloni and Pandya (1999) . Regions of the posterior parietal cortex were defined in accordance with Cavada and Goldman-Rakic (1989) in which area 5 corresponds to area PE and areas 7m, 7a, and 7b correspond to areas PGm, PG, and PF of Pandya and Seltzer (1982) , respectively. Regions of the intraparietal sulcus were designated as physiologically defined areas MIP, VIP, and LIP (reviewed in Colby and Goldberg 1999) but are architectonically analogous to area PEa and POa of Pandya and Seltzer (1982) and area 7ip of Cavada and Goldman-Rakic (1989) . Visual regions of the parietooccipital cortex (MT, MST, FST) were defined based on the studies of Boussaoud and others (1990) and Lewis and Van Essen (2000) . The laminar boundaries of area 17 were delineated based on the divisions of Fitzpatrick and others (1985) . The nuclear divisions of the amygdala were defined according to Amaral and Bassett (1989) and Pitkanen and Amaral (1998) . Regions of the hippocampal formation and layers of the dentate gyrus (DG) and CA regions followed the terminology of Alonso and Amaral (1995) and Jongen-Relo and others (1999) . Cerebellar lobules and folia were defined according to the atlas of Madigan and Carpenter (1971) . Finally, laminar boundaries in human neocortical regions were identified using published cytoarchitectonic criteria (Table 1) (Braak 1976; Rajkowska and Goldman-Rakic 1995) .
Photography
Brightfield photomicrographs were obtained with a Zeiss Axiocam camera. Digital electron micrographs and brightfield photomontages were assembled, and the brightness and contrast were adjusted in Adobe Photoshop.
Results
Specificity of the CB 1 Antibodies
The specificity of the C-terminus CB 1 antibodies was tested by omission of the primary antibodies and by preadsorption of the anti-CB 1 --CT and anti-CB 1 --L15 antibodies with their respective fusion proteins. All specific immunoreactivity was eliminated in monkey tissue under these conditions. When the anti-CB 1 --L15 antibody was preadsorbed with the anti-CB 1 --CT fusion peptide, all specific immunoreactivity was eliminated. However, when the anti-CB 1 --CT antibody was preadsorbed with the anti-CB 1 --L15 fusion peptide, some specific labeling of axons remained, indicating that the overlapping but shorter anti-CB 1 --L15 fusion peptide contained some, but not all, epitopes recognized by the anti-CB 1 --CT antibody. Furthermore, although raised against different amino acid sequences of the CB 1 receptor, all 3 antibodies produced identical patterns of immunoreactivity in the neocortex (Fig. 1) . Specifically, each of the CB 1 antibodies labeled numerous thin, highly varicose axons with a distinctive laminar pattern of distribution ( Fig. 1A --C). In addition, dense perisomatic arrays of labeled processes around unlabeled cell bodies ( Fig. 1D--F) and a small number of intensely immunoreactive cell bodies restricted to neocortical layers 2 and superficial 3 were observed with all 3 antibodies ( Fig. 1A --C). Consistent with other reports (Hajos and others 2000; Katona and others 2001) , the C-terminus antibodies (Fig. 1A,B ,D,E) produced more intense immunoreactivity with a better signal-to-noise ratio than the N-terminus antibody (Fig. 1C,F) . We therefore used the C-terminus antibodies in our analyses.
Distribution of CB 1 Immunoreactivity in Monkey Neocortex
Regional Densities
The overall distribution of CB 1 -IR axons varied substantially across different neocortical regions in each of the animals examined (Table 2) . Specifically, the highest densities of CB 1 -IR axons in the neocortex were present in higher-order association regions, such as the prefrontal cortex, whereas the primary visual cortex had the lowest density of CB 1 -IR axons. Within the frontal lobe, dorsolateral prefrontal area 46, followed by dorsal area 9 and rostral area 10, contained the highest densities of CB 1 -IR axons. From these areas the density of CB 1 -IR axons progressively declined both caudally (across areas 8, 6, and 4) and ventrally (across areas 11 and 13) (Fig. 2) . The primary motor cortex (area 4) contained the lowest overall density of CB 1 -IR axons in the frontal lobe ( Fig. 3 ). For instance, the densities CB 1 -IR axons in areas 24b--d, 23b--d, and 31 were similar to that observed in prefrontal areas 9 and 10. However, areas 24a, 23a, 29, and 30 exhibited a lower density of CB 1 immunoreactivity (Table 2 ; Fig. 3 ).
In the medial temporal cortex, all fields of the entorhinal cortex (E I and E C illustrated) and adjacent area 36 exhibited a high density of CB 1 -IR axons ( Table 2; Figs. 3 and 8A). Visual area TEO in the inferior temporal cortex contained an intermediate density of CB 1 -IR axons, whereas rostral region TE (Fig. 3) contained a moderate to high CB 1 -IR axon density. In the superior temporal gyrus, auditory association areas contained a high CB 1 -IR axon density, with parabelt regions RP and CP exhibiting slightly higher CB 1 -IR axon densities than the adjacent belt regions AL and ML ( Figs. 3 and 7A ). The dysgrangular region of the insula (Idg) contained a lower density of CB 1 -IR axons than the prefrontal cortex, and labeled axon density was further reduced in the granular region of the insula (Ig) (Table 2; Fig. 3 ).
In the postcentral gyrus of the parietal cortex, primary somatosensory areas 3, 1, and 2 had a relatively low density of CB 1 -IR axons, similar to that observed in primary motor area 4 (Table 2; Fig. 3 ). Area SII on the dorsal bank of the lateral fissure showed a slightly higher density of CB 1 -IR axons. Areas 7 and 5 of the posterior parietal cortex contained a high density of CB 1 -IR axons similar to that observed in the prefrontal cortex, whereas areas MIP, VIP, and LIP in the intraparietal sulcus exhibited only an intermediate expression of CB 1 -IR axons ( Table 2) .
The lowest overall density of CB 1 -IR axons in the neocortex was present in the primary visual cortex (area 17), with area 18 demonstrating a slightly higher density of CB 1 -IR axons ( Table  2) . Higher-order visual areas MT, MST, and FST demonstrated intermediate densities of CB 1 -IR axons ( Table 2) .
Laminar Patterns
The laminar distribution of CB 1 -IR axons also varied substantially across different neocortical regions in each of the animals examined. Most association areas, such as the prefrontal cortex Note: Relative density values represent qualitative assessments of the intensity of CB 1 immunoreactivity on a scale of 0-10 with 0 representing the absence of detectable CB 1 immunoreactivity and 10 representing the highest intensity of CB 1 immunoreactivity. Examples of points along this scale are provided as follows: 0 ( Fig. 3) , 2 (Fig. 5B) ; 4 ( Fig. 2) ; 6 ( Fig. 3) ; 8 (Fig. 2) , 10 ( Fig. 3) .
Cerebral Cortex January 2007, V 17 N 1 179 ( Figs. 1 and 2) , parietal area 7m (Fig. 4A) , and cingulate areas 23b--d, 24b--d, and 31 ( Fig. 3) , had a similar laminar distribution of CB 1 -IR axons. For example, in prefrontal area 46 (Fig. 1) , the density of CB 1 -IR axons was lowest in layer 1 and progressively increased from superficial to deep across layers 2 and 3. Layer 4 contained a very dense band of immunoreactive axons and varicosities and layer 6 contained a band of lower density. The low level of immunoreactivity in layer 5 sharply demarcated the borders with layers 4 and 6. The presence of distinct radial fibers also distinguished layers 3 and 5. The somewhat lower overall density of CB 1 -IR axons in some other association regions was due to a lower density of positive axons in layer 4. For instance, areas 24a ( Fig. 4B ) and 23a (Fig. 3 ) of the cingulate cortex showed a fairly homogenous distribution of CB 1 -positive axons across layers 2--6. In contrast, in the E I and E C subdivisions of the entorhinal cortex ( Fig. 4C) , layers 2 and 5 contained the highest density of CB 1 -IR axons and varicosities, and the density was lower in layers 3 and 6. The lower density of radially oriented CB 1 -IR axons in layer 3 in E C and layers 3 and 4 in E I highlighted distinct borders with layers 2 and 5. Layer 2 of E I contained patches of high and low densities of CB 1 -IR axons that correspond to the islands of multipolar cells separated by cell-sparse zones that are characteristic of this region (Fig. 3) . Layer 1 of the entorhinal cortex contained diffuse horizontally oriented CB 1 -IR axons unlike other neocortical association regions (Fig. 4) .
The laminar pattern of CB 1 -IR axons was quite different in primary motor (Fig. 2) and somatosensory cortices (Fig. 5A) , where the density of CB 1 -IR axons was greatest in layers 2--3 and 5--6 and lowest in layer 4. The primary visual cortex was unique in that the highest density of CB 1 -IR axons was observed in layers 5--6, layers 1--3 exhibited diffuse horizontally oriented axons, and layer 4 demonstrated a complete absence of CB 1 -IR axons (Fig. 5B) . The laminar distribution of CB 1 -IR axons in higher-order visual areas such as area FST was homogeneous across layers (Fig. 5C) . These qualitative regional differences in laminar distribution of CB 1 -IR axons were confirmed by optical density measures ( Fig. 6 ). For example, optical density across layers in area 46 (Fig. 6A ), area 24a (Fig. 6B ), area 2 (Fig. 6C) , and area 17 ( Fig.  6D ) precisely matched the laminar distribution of CB 1 -IR axons observed in these areas qualitatively.
The differences in density and laminar distribution of CB 1 -IR axons were so striking that many boundaries between cytoarchitectonic regions were clearly delineated by CB 1 immunoreactivity ( Fig. 7) . For instance, the boundary between primary auditory cortex AI and the adjacent auditory association belt cortex area ML in the superior temporal gyrus was clearly distinguished by the appearance of a dense band of CB 1 -IR axons in layer 4 of ML (Fig. 7A ). In the posterior parietal cortex, the border between area 5 and MIP could be delineated by the disappearance of a dense band of CB 1 -IR axons in layer 4 of MIP (Fig. 7B ). In the visual cortex, the area 17/18 border was clearly identified by an increase in axon density in layers 2--4 of area 18 (data not shown).
Other Brain Regions
In order to place the relative density of CB 1 -labeled structures in the neocortex in a broader context, we also evaluated a sampling of other brain regions.
Hippocampal Formation
The hippocampus contained overall a high density of CB 1 -IR axons that was similar to the density of labeled axons observed in the prefrontal cortex (Table 2) . A dense meshwork of immunolabeled beaded axons was present throughout all regions of the hippocampal formation (Table 2; Fig. 8 ). In the CA1--CA3 fields, the pyramidal cell layer (PCL) demonstrated a high density of CB 1 -IR axons that surrounded unlabeled pyramidal cells (Fig. 8A,B) . The stratum lacunosum-moleculare (SLM) also exhibited a high density of CB 1 -IR axons ( Table 2; Fig.  8A,B) , whereas the stratum oriens (SO) and stratum radiatum (SR) in CA1--CA3 of the hippocampus showed a slightly lower density of CB 1 -IR axons ( Table 2 ; Fig. 8A,B) . The stratum lucidum (SL) of the CA3 region demonstrated the lowest Figure 2 . Brightfield photomicrograph of a parasagittal section through macaque monkey frontal lobe processed for CB 1 immunoreactivity. CB 1 -IR axon density was greatest in prefrontal regions such as the dorsolateral prefrontal cortex (area 46) within the principal sulcus (ps). The overall density of CB 1 -IR axons decreased and the laminar patterns changed (arrows) from rostral prefrontal areas to motor areas (areas 4 and 6) caudal to the arcuate sulcus (as). On the orbital surface, labeled axon density also decreased from dorsal (area 10) to ventral (area 13) regions. Scale bar = 2 mm. density of CB 1 -IR axons ( Table 2 ; Fig. 8A,B) . CB 1 -IR axons appeared to radiate through the SL in parallel with pyramidal cell dendrites, whereas in the SO, SR, and SLM regions, CB 1 -IR axons appeared to travel perpendicular to dendrites originating from pyramidal cells in the PCL (Fig. 8B) . The subicular regions demonstrated a high density of CB 1 -IR axons, although the density was somewhat lower than that present in the CA regions (Fig. 8A) .
The DG was distinguished by an extremely low density of CB 1 labeling in the granule cell layer (GL), which appeared as a prominent immunonegative strip at low magnification (Fig.  8A) . Similar to the PCL in the CA regions, granule cells were always immunonegative for CB 1 ; however, in contrast to the PCL, CB 1 -IR axons appeared to radiate through the GL without surrounding unlabeled granule cells except at the border of the infragranular plexus (Fig. 8C) . The outer molecular layer (OML) contained a very high density of CB 1 -IR axons, whereas the molecular layer (MLdg) contained a slightly lower density of CB 1 -IR axons (Fig. 8A,C) . The polymorphic layer (PLdg) had a somewhat lower density of CB 1 -IR axons compared with MLdg ( Fig. 8C ).
Amygdala
The pattern of CB 1 immunolabeling clearly followed the boundaries of several nuclei in the monkey amygdala ( Figs. 3  and 9C ). The most intense CB 1 immunoreactivity was observed in the cortical-like basolateral complex (Table 2; Figs. 3 and 9C) , where a dense meshwork of varicose axons surrounded Figure 3 . Photomicrograph of a coronal section through macaque monkey brain illustrating the distribution of CB 1 -IR axons. Association areas such as the cingulate cortex (area 23), insula (Ig, Idg), auditory association cortex (RP), and the entorhinal cortex (E I ) had an overall higher density of CB 1 -IR axons than primary somatosensory areas (areas 3, 1, 2) and primary motor cortex (area 4). Also note the distinct differences in the laminar distribution of labeled processes at the boundaries of some cytoarchitectonic regions (arrows). In subcortical structures, the intensity of CB 1 immunoreactivity was high in the claustrum (Cl), the basal and lateral nuclei of the amygdala, and both segments of the globus pallidus (GP); intermediate to low in the caudate (Cd) and putamen (Pu) and the central and medial nuclei of the amygdala; and not detectable in the thalamus (Th). Boxes indicate regions shown at higher magnification in Figure 9 . Scale bar = 2 mm.
Cerebral Cortex January 2007, V 17 N 1 181 Figure 5 . Brightfield photomicrographs demonstrating differences in density and laminar distribution patterns of CB 1 -IR axons across sensory regions. All sensory regions showed an overall lower density of CB 1 -IR axons than association regions. (A) Primary somatosensory cortex (area 2) contained a relatively low density of CB 1 -IR axons. The density of CB 1 -IR axons was similar across layers 2--3 and 5--6, and there was a paucity of labeling in layer 4. (B) Primary visual cortex (area 17) showed the overall lowest density of CB 1 -IR axons in the cortex. The laminar pattern of CB 1 -IR axons in area 17 was unique in that layers 5--6 contained the highest density of labeled axons and layer 4 contained no labeled axons. (C) Higher-order visual areas, such as area FST, contained an overall CB 1 -IR axon density that was lower than other association regions, and the laminar distribution of CB 1 -IR axons was homogeneous across layers. Numbers and hash marks to the left of each panel indicate the relative positions of the cortical layers, and the dashed lines denote the layer 6-white matter (WM) border. Scale bar = 300 lm in C (applies to A, B, C) . CB 1 -immunonegative cell bodies (Fig. 9C ). In the basolateral complex, the density of CB 1 -IR axons was greatest in the Bmc, Bi, ABmc, and Lvi nuclei (Fig. 3) , whereas the more ventral and lateral ABpc, Bpc, Ldi, and Lv nuclei contained slightly fewer CB 1 -IR axons. The overall density of CB 1 -IR axons in the basolateral nuclei was similar to that observed in the prefrontal cortex (Table 2 ). In the striatal-like central (Ce) and medial (Me) nuclei of the monkey amygdala, no CB 1 -IR axons were evident (Table 2; Figs. 3 and 9C ). In these nuclei, light labeling above that in the white matter was observed; however, this immunoreactivity was morphologically indistinct.
Basal Ganglia, Cerebellum, Thalamus, and Claustrum As summarized in Table 2 , CB 1 immunoreactivity was present throughout the basal ganglia, but each nucleus exhibited a pattern of immunoreactivity that differed from other components of the basal ganglia and from regions of the neocortex. The caudate nucleus (Cd) and putamen (Pu) contained sparsely distributed, thin, varicose, labeled processes, as well as a diffuse immunoreactivity that was morphologically indistinct (Table 2 ; Figs. 3 and 9A,B) . The globus pallidus (GP), which exhibited the most intense CB 1 immunoreactivity of the brain regions examined (Table 2; Figs. 3 and 9B) , contained a very dense Figure 7 . Brightfield photomicrographs illustrating shifts in CB 1 -IR axon density and laminar distribution at cytoarchitectonic boundaries. (A) CB 1 -IR axon density was greater in association auditory cortex (ML and CP) compared with primary auditory cortex (AI). Note the appearance of a dense band of CB 1 -IR axons in layer 4 at the border of AI--ML (arrow) that becomes even more distinct at the border of ML--CP (arrowhead). (B) In posterior parietal cortex, the boundary between area 5 and MIP was marked by a decrease in overall CB 1 -IR axon density and disappearance of a dense layer 4 band of CB 1 -IR axons (arrow). The transition between areas MIP and VIP was also marked by a slight decrease in overall CB 1 -IR axon density (arrowhead). Scale bars = 500 lm. Figure 1B (area 46), Figure 4B (area 24a), and Figure 5A (area 2) and B (area 17). For each area optical density measures were divided into 100 bins, and within each region optical density measures were normalized by dividing the value of each bin by the value of the maximum bin. Note the marked regional differences in laminar distribution patterns.
Cerebral Cortex January 2007, V 17 N 1 183 meshwork of thin, smooth, CB 1 -IR processes that encircled large unstained fascicles, cell bodies, and wooly fibers (Fig. 9B) . The substantia nigra pars reticulata (SNr) demonstrated CB 1 immunoreactivity identical to that observed in the GP (data not shown). The thalamus (Th) appeared to be completely devoid of CB 1 -IR axons (Fig. 3) . The claustrum (Cl) exhibited a high density of CB 1 -IR highly varicose, axonal processes (Table 2) , similar to those present in the adjacent insular cortex (Fig. 9A) . As in the neocortex, axons in the Cl were found to surround immunonegative cell bodies.
In the cerebellum, most lobules contained a high intensity of CB 1 immunoreactivity with a distinctive laminar pattern (Fig. 10) . The intensity of CB 1 immunoreactivity was greatest in the molecular layer and lowest in the granular layer (Table 2 ; Fig. 10 ). Intense CB 1 immunoreactivity coated the basilar portion of Purkinje cell bodies in a triangular cap-like fashion reminiscent of the pinceau synapses furnished by basket interneurons (Fig. 10B) . However, Purkinje cell bodies and dendrites were always CB 1 immunonegative (Fig. 10B ). Although this pattern of CB 1 immunoreactivity was present in most lobules, lobule X was notable for containing a very low level of CB 1 immunoreactivity in the molecular layer (Fig. 11) .
Comparison with Human Neocortex
The distribution of CB 1 -IR axons in the human prefrontal and primary visual cortices was very similar to that observed in homologous regions of the monkey neocortex with a few exceptions. As in the monkey, human prefrontal area 46 exhibited a much higher density of CB 1 -IR axons than primary visual cortex area 17 (Fig. 12 ). In the human prefrontal cortex (Fig. 12A) , layer 5 contained the lowest density of CB 1 -IR axons, layers 2--3 contained a moderate density of CB 1 -IR axons, and layer 4 contained the highest density of CB 1 -IR axons, similar to that observed in the monkey. However, in contrast to the monkey, the density of CB 1 -IR axons in layer 6 did not appear to be greater than in layer 5. In human area 17 (Fig. 12B) , the laminar distribution of CB 1 -IR axons was identical to the monkey. However, layers 1--3 contained a greater density CB 1 -IR axons and layer 4 appeared to contain slightly more CB 1 -IR radial axons, whereas layers 5--6 exhibited a lower density of Figure 8 . (A) Brightfield photomicrograph of a coronal section through macaque medial temporal lobe illustrating the distribution of CB 1 -IR axons in the hippocampal formation and adjacent entorhinal cortex (E C ). A dense meshwork of CB 1 -IR beaded axons was observed throughout the entire hippocampal formation. Note the distinct laminar pattern of CB 1 -IR axons in the E C compared with area 36. (B) In the CA regions of the hippocampus, the highest density of CB 1 -IR axons was located in the pyramidal cell layer (PCL) and stratum lacunosum-moleculare (SLM) and the lowest density of CB 1 -IR axons was located in the stratum oriens (SO) stratum lucidum (SL). (C) In the dentate gyrus, the highest density of CB 1 -IR axons was observed in the outer molecular layer (OML) and infragranular plexus (arrow). The granule cell layer (GL) contained the lowest density of CB 1 -IR axons, and granule neurons were always CB 1 immunonegative. Scale bar = 1 mm in A; 150 lm in B (applies to B, C). CB 1 -IR axons than in the monkey (Fig. 12B) . Finally, the morphology of CB 1 -IR axons in the human neocortex differed slightly from that observed in the monkey. In the human neocortex (Fig. 13C) , the intervaricose segments of CB 1 -IR axons were less distinct and boutons appeared to be larger and swollen compared with those in the perfused monkey neocortex (Fig. 13A) . These morphological differences appeared to reflect a postmortem effect. In unperfused monkey tissue with different postmortem delays before fixation, the intervaricose segments of CB 1 -IR axons became less distinct and boutons became more swollen with longer delays (Fig. 13B ).
Electron Microscopy
Electron microscopy studies were performed in layer 4 of monkey area 46 in order to assess the cellular distribution of the CB 1 receptor (Fig. 1A) . CB 1 immunoreactivity was found in axon terminals forming symmetric synapses (Gray's type II) (Fig.  14A ). Asymmetric synapses (Gray's type I), dendrites, and dendritic spines did not appear to be immunoreactive for the CB 1 receptor (Fig. 14A) . When CB 1 immunoreactivity was observed in cell bodies, they had the characteristic features of GABA neurons such as invaginated nuclei. The immunoperoxidase reaction product in cell somas was associated with the Golgi apparatus and endoplasmic reticulum but was not found near the plasma membrane (Fig. 14B ).
Discussion
The results of this study demonstrate that 1) the distribution of CB 1 -IR axons is heterogeneous across neocortical regions of the macaque monkey with regions associated with higher cognitive functions, such as the prefrontal cortex, containing higher densities of CB 1 -IR axons than primary motor and sensory cortices; 2) different neocortical regions exhibit distinctive laminar distributions of CB 1 -IR axons, which precisely mark the cytoarchitectonic boundaries between many regions; 3) the density and distribution of CB 1 -IR axons also differ substantially across other regions of the primate brain; 4) the regional and laminar distributions of CB 1 -IR axons in the human neocortex are quite similar to those in monkey, although the morphology of labeled axons is altered by postmortem delay and; 5) in the monkey neocortex, CB 1 Figure 9 . Higher magnification photomicrographs of boxed regions in Figure 3 illustrating different patterns of CB 1 immunoreactivity in subcortical structures. (A, B) Immunoreactivity in the putamen (Pu) was enhanced pericellularly with some evidence of sparsely distributed, thin, varicose processes, but most immunoreactivity was morphologically indistinct. Immunoreactivity in the claustrum (Cl) was localized to axon processes and boutons, similar to that found in the adjacent granular insular cortex (Ig). (B) The globus pallidus (GP) contained a very dense meshwork of thin smooth CB 1 -IR processes that appeared to encircle unstained compartments such as cell bodies and wooly fibers. immunoreactivity is primarily contained in cells and axon terminals that have the morphologic features characteristic of GABA neurons.
Methodological Considerations
Several lines of evidence indicate that the antibodies used in this study are selective for the central CB 1 receptor. First, 3 antibodies raised against different portions of the CB 1 receptor produced identical patterns of immunoreactivity. Second, preadsorption with the cognate peptides eliminated specific immunoreactivity. Third, previous studies confirmed the specificity of the anti-CB 1 --CT antibody by demonstrating the elimination of immunoreactivity in CB 1 knockout mice, the identification of bands of appropriate molecular weight in western blot analysis, and the labeling of cultured cells transfected with the CB 1 receptor (Hajos and others 2000; Katona and others 2001) .
Previous studies employing immunocytochemistry in both rat (Tsou and others 1998) and monkey (Lu and others 1999; Ong and Mackie 1999) using antibodies raised against the first 77 N-terminus amino acids of the CB 1 receptor reported Figure 10 . CB 1 immunoreactivity in the monkey cerebellar cortex. (A) Low-power brightfield photomicrograph demonstrating intense CB 1 immunoreactivity in the molecular layer (M) and lower CB 1 immunoreactivity in the granular layer (G) of the cerebellum. (B) High-power brightfield photomicrograph illustrating CB 1 immunoreactivity in the molecular, Purkinje, and granule cell layers of the cerebellum. The somata and dendrites of Purkinje cells were always CB 1 immunonegative (asterisks). Note the dense triangular, pinceau synapse-like immunolabeling surrounding the basal portion of Purkinje cells. Scale bars = 300 lm in A; 50 lm in B. Figure 11 . Low-power brightfield photomicrograph illustrating CB 1 immunoreactivity in the nodulus (lobule X) and uvula (lobule IX) of the cerebellum. The intensity of CB 1 immunoreactivity was very low in the molecular layer (M) of lobule X and increased caudally in lobule IX. Lobular differences in the granular layer (G) were much less marked. Scale bar = 1 mm. a significantly lower density and less distinct laminar pattern of axon labeling and a much greater density of labeled cells including interneurons and pyramidal neurons. These differences in patterns of immunoreactivity could reflect the phosphorylation state of the C-terminus of the CB 1 receptor, which mediates CB 1 receptor internalization (Hsieh and others 1999) . As suggested by Egertova´and Elphick (2000), the last 13 amino acids of the CB 1 receptor contain 6 sites that when phosphorylated may render the CB 1 receptor nonimmunoreactive to antibodies directed against the C-terminus. Therefore, internalized receptors in cell bodies may not be recognized by Cterminus antibodies. However, we observed immunoreactivity within cell bodies, including labeling associated with cytoplasmic organelles, as has been reported in rodents using the same C-terminus antibodies (Hajos and others 2000; Katona and others 2001; Bodor and others 2005) . Furthermore, in the present study we observed identical patterns of immunoreactivity with both C-terminus and N-terminus antibodies. Together, these data indicate that the C-terminus antibodies used in this study recognize CB 1 receptors whether they are inserted in the plasma membrane or internalized.
Some studies suggest that CB 1 receptors might be present presynaptically in pyramidal cell axon terminals where they could affect glutamate release. For instance, low levels of CB 1 mRNA have been observed in pyramidal neurons (Marsicano and Lutz 1999) , and the application of CB 1 agonists has been reported to reduce the amplitude of excitatory postsynaptic These findings could reflect alternative splicing of the Nterminus CB 1 receptor to form a variant of the CB 1 receptor (CB 1A ) (Shire and others 1995; Egertova´and Elphick 2000) . In the proposed CB 1A splice variant, the first 61 amino acids of the CB 1 receptor are replaced by 28 amino acids that are unrelated to the full CB 1 receptor. It could be argued that it is the CB 1A splice variant that is expressed by pyramidal neurons; however, the C-terminus antibodies used in this study would recognize both isoforms of the CB 1 receptor, yet only inhibitory neurons, axons, and terminals were found to contain CB 1 immunoreactivity. Alternatively, a yet unidentified cannabinoid receptor (or receptors) might be present in glutamatergic neurons (Begg and others 2005) . This hypothesis is supported by findings that the ability of WIN 55212-2 (a CB 1 receptor agonist) to block inhibitory postsynaptic currents is abolished in CB 1 knockout mice, whereas its ability to prevent excitatory postsynaptic currents persists (Hajos and others 2001) . In addition, WIN 55212-2 binds to tissue of CB 1 knockout mice, but with lower affinity than in wild-type mice (Breivogel and others 2001) .
Regional and Laminar Distributions of CB 1 -Containing Axons CB 1 -IR axons were present throughout the monkey and human neocortex but showed marked regional variations in overall densities and laminar distributions. For example, the overall density of CB 1 -IR axons was much higher in association areas, such as the prefrontal cortex, than in primary sensory and primary motor regions. The distribution of CB 1 immunoreactivity across monkey neocortical regions was broadly similar to that observed in the rat with several C-terminus antibodies (Egertova´and Elphick 2000; Hajos and others 2000; Katona and others 2001; Bodor and others 2005) and to the distribution of CB 1 receptor--binding sites (Herkenham and others 1991) . However, some species differences in the laminar distribution of CB 1 -IR axons are worth noting. For instance, Egertova´and Elphick (2000) reported that CB 1 -IR axons were most densely localized in layers 2--3 and 6 and least dense in layer 4 of the rat frontal and cingulate cortices, whereas the monkey layer 4 contained the highest density of CB 1 -IR axons in these regions. Furthermore, the dense band of CB 1 -IR axons in layer 5A, bordered by sparse axon labeling in layers 4 and 5B, in the rat somatosensory cortex (Bodor and others 2005) differs from the relatively similar density of axons across layers 2--3 and 5--6 and sparse axonal labeling in layer 4 in the monkey primary somatosensory cortex. In contrast to the differences observed in the laminar distribution of CB-IR axons in the monkey and rat, the laminar distribution of CB 1 -IR axons across homologous regions of the monkey and human is nearly identical. Furthermore, the laminar distribution of CB 1 receptor--binding sites in the human revealed by autoradiography (Glass and others 1997) is quite similar to that of CB 1 -IR axons observed here.
The various laminar distributions of CB 1 -IR axons across the monkey neocortex raise the question of whether some CB 1 -IR axons could arise from extrinsic sources. Although the band of CB 1 -IR axons in layer 4 of some regions suggests a thalamic source for these axons, the absence of labeling in terminals forming asymmetric synapses (this study; others 1999, 2001; Hajos and others 2000; Bodor and others 2005) and the complete absence of CB 1 immunoreactivity in the thalamus excludes this source. In contrast, the presence of CB 1 immunoreactivity in cell bodies and terminals with the morphological features of GABA neurons suggests that the most likely source of neocortical CB 1 -IR axons is intrinsic inhibitory local circuit interneurons. This idea is supported by a recent study demonstrating that the axons of intracellularly labeled CB 1 -IR cells in layers 2--3 of the mouse neocortex arborized extensively within layers 2--3 but also projected into layers 4--6 (Galarreta and others 2004). Furthermore, recent evidence suggests that neocortical neurons containing CB 1 receptors belong to the subpopulation of large basket GABA neurons that contain the neuropeptide CCK (Bodor and others 2005) . Indeed, experiments in the rodent neocortex revealed that nearly all neurons expressing high levels of CB 1 mRNA also express CCK mRNA and that inhibitory terminals containing CB 1 immunoreactivity Figure 14 . Electron micrographs demonstrating CB 1 immunoperoxidase labeling in area 46 of monkey prefrontal cortex. (A) CB 1 immunoreactivity in an axon terminal (at) forming a symmetric synapse (arrow) onto an unlabeled dendrite (D). Terminals forming asymmetric synapses (arrowhead) were always CB 1 immunonegative. (B) Low-power electron micrograph demonstrating CB 1 labeling in the cell body of a putative GABA interneuron as evidenced by an invaginated (asterisk) nucleus (N). Reaction product was associated with the Golgi apparatus and rough endoplasmic reticulum but not found near the plasma membrane. Scale bars = 500 nm. also contain CCK immunoreactivity (Marsicano and Lutz 1999; Bodor and others 2005) . Furthermore, both the laminar pattern of CB 1 -IR neurons and axons and the perisomatic arrays formed by CB 1 -IR processes observed in this study directly match the findings of CCK-IR structures in monkey neocortex Lewis 1990, 1993) .
Functional Implications
In the rodent, activation of CB 1 receptors inhibits the release of GABA from presynaptic terminals and reduces GABA A receptor-mediated inhibitory postsynaptic currents in pyramidal neurons in the neocortex (Galarreta and others 2004; Trettel and others 2004; Bodor and others 2005) . Furthermore, the binding of endocannabinoids to CB 1 receptors in vitro mediates depolarization suppression of inhibition (DSI) in the rodent neocortex (Trettel and others 2004; Bodor and others 2005) . In this phenomenon, repetitive firing of pyramidal neurons produces elevated intracellular calcium levels, which initiates the synthesis and retrograde release of endocannabinoids. The released endocannabinoids bind to presynaptic CB 1 receptors located on CCK terminals resulting in the reduction of proximal inhibitory input to that same pyramidal neuron (reviewed in Wilson and Nicoll 2002) . Thus, DSI in the neocortex is a mechanism by which pyramidal neurons can self-regulate their perisomatic inhibitory input.
These data suggest that CB 1 receptors play an important role in regulating network activity patterns by controlling proximal inhibitory input to pyramidal neurons during prolonged firing. Synchronous rhythmic activity appears to arise from the coordinated firing of electrically coupled interneurons belonging to the same population, which then entrain the spike timing of large cell ensembles (reviewed in Connors and Long 2004) . Although fast-spiking, PV-containing neurons are the major cell type necessary for rhythmically entraining pyramidal cells to fire in the gamma range, CB 1 /CCK basket neurons may be necessary for fine-tuning network oscillations (Freund 2003) . Indeed, in the rat hippocampus CB 1 agonists significantly reduce the amplitude of gamma-band oscillations suggesting that the activation of CB 1 receptors disinhibit pyramidal cells and prevent them from firing in synch (Hajos and others 2000) .
These functional data in rodents, in concert with the high density of CB 1 -IR axons in the prefrontal cortex of monkeys and humans observed in this study, suggest that the endocannabinoid system may modulate cognitive functions, such as working memory. Indeed, in the human prefrontal cortex gamma-band power increases directly and in proportion to working memory load (Howard and others 2003) , and the systemic administration of cannabinoids disrupts the ability to perform working memory tasks in both humans and animals (Winsauer and others 1999; Schneider and Koch 2003; D'Souza and others 2004) . This disruption in cognitive abilities following cannabis use might be due, at least in part, to decreased GABA transmission in the prefrontal cortex (Pistis and others 2002) , which is critical for performance of working memory tasks (Sawaguchi and others 1988; Rao and others 2000) . Interestingly, the working memory deficits commonly observed in individuals with schizophrenia (Callicott and others 2003) are associated with both reduced gamma band power and deficient perisomatic input to pyramidal neurons from parbalbumin-containing GABA neurons (Lewis and others 2005) . Thus, activation of CB 1 receptors through the use of exogenous cannabinoids could result in an additional deficit in perisomatic GABA input to pyramidal neurons in individuals with schizophrenia by inhibiting GABA release from CCK basket interneurons. Furthermore, the reported upregulation of CB 1 receptor--binding sites in patients with schizophrenia might heighten the effect of endogenous and exogenous cannabinoids (reviewed in Ujike and Morita 2004) . These observations suggest that excessive signaling via CB 1 receptors, in the context of a deficit in inhibition from PV-containing GABA neurons, impairs the gamma oscillatory activity in the prefrontal cortex and contributes to certain cognitive deficits in individuals with schizophrenia. Future studies investigating the physiological role of CB 1 receptors in the monkey prefrontal cortex and of the integrity of CB 1 receptors in the prefrontal cortex of individuals with schizophrenia may provide critical insight into the role of exogenous cannabinoids and CB 1 receptors in the cognitive deficits associated with schizophrenia.
Notes
